Cargando…
Erratum to “Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites” [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117–126]
Autores principales: | Engel, Jessica A., Jones, Amy J., Avery, Vicky M., Sumanadasa, Subathdrage D.M., Ng, Susanna S., Fairlie, David P., Skinner-Adams, Tina, Andrews, Katherine T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196483/ https://www.ncbi.nlm.nih.gov/pubmed/27682348 http://dx.doi.org/10.1016/j.ijpddr.2016.05.001 |
Ejemplares similares
-
Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites
por: Engel, Jessica A., et al.
Publicado: (2015) -
Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]
por: LoVerde, Philip T., et al.
Publicado: (2022) -
Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]
por: Jesus, Jessica A., et al.
Publicado: (2017) -
Corrigendum to “Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes” [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174–180]
por: Gomes, Ana Rita, et al.
Publicado: (2017) -
Corrigendum to ‘the anti-fecundity effect of 5-azacytidine (5-AzaC) on Schistosoma mansoni is linked to dis-regulated transcription, translation and stem cell activities’ [Int. J. Parasitol. Drugs and Drug Resist. 8 (2018) 213–222]
por: Geyer, Kathrin K., et al.
Publicado: (2018)